TD Bank reports 3,025,945 PTC Therapeutics shares
PTC Therapeutics ownership update: The Toronto-Dominion Bank reports beneficial ownership of 3,025,945 shares of common stock, representing 3.7% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PTC Therapeutics ownership update: The Toronto-Dominion Bank reports beneficial ownership of 3,025,945 shares of common stock, representing 3.7% of the class. The filing is an Amendment No. 1 to a Schedule 13G/A and is signed on 05/15/2026.
The statement lists sole voting and sole dispositive power over the same 3,025,945 shares. The filing notes ownership is 5% or less of the class.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficially owned financial
Sole Dispositive Power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does The Toronto-Dominion Bank hold in PTC Therapeutics (PTCT)?
What type of SEC filing did TD Bank submit for PTCT?
When was the Schedule 13G/A amendment signed for PTCT?
Does the filing indicate TD Bank controls more than 5% of PTCT?
AI-generated analysis. How Rhea-AI works. Not financial advice.